Geode Capital Management
NMTC icon

Geode Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Geode Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96.4K Hold
93,555
– – ﹤0.01% 4069
2026
Q2 		$284K Sell
93,555
-9,046
-9% -$36.9K ﹤0.01% 3803
2026
Q1 		$478K Buy
102,601
+18,516
+22% +$88.9K ﹤0.01% 3596
2025
Q4 		$382K Buy
84,085
+1,279
+2% +$5.82K ﹤0.01% 3694
2025
Q3 		$442K Buy
82,806
+24,668
+42% +$121K ﹤0.01% 3667
2025
Q2 		$237K Buy
58,138
+475
+0.8% +$1.75K ﹤0.01% 3821
2025
Q1 		$294K Buy
57,663
+5,720
+11% +$36.3K ﹤0.01% 3728
2024
Q4 		$257K Buy
51,943
+4,634
+10% +$23.1K ﹤0.01% 3816
2024
Q3 		$281K Buy
47,309
+4,162
+10% +$20.8K ﹤0.01% 3790
2024
Q2 		$207K Buy
43,147
+6,155
+17% +$38.7K ﹤0.01% 3894
2024
Q1 		$266K Buy
36,992
+4,138
+13% +$31.3K ﹤0.01% 3840
2023
Q4 		$312K Buy
32,854
+3,144
+11% +$23.2K ﹤0.01% 3788
2023
Q3 		$159K Buy
29,710
+8,227
+38% +$55.1K ﹤0.01% 4069
2023
Q2 		$155K Buy
21,483
+2,441
+13% +$19.8K ﹤0.01% 4160
2023
Q1 		$184K Hold
19,042
– – ﹤0.01% 4093
2022
Q4 		$137K Sell
19,042
-52
-0.3% -$465 ﹤0.01% 4276
2022
Q3 		$193K Buy
19,094
+10,975
+135% +$104K ﹤0.01% 4236
2022
Q2 		$39K Buy
8,119
+1,911
+31% +$10.6K ﹤0.01% 4824
2022
Q1 		$40K Buy
+6,208
New +$75.2K ﹤0.01% 4847

Other funds holding NMTC

Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Belpointe Asset Management
Belpointe Asset Management Reno, Nevada $3.63B AUM 17.81% 1-Year Est. Return

Geode Capital Management's NMTC Position: Q3 2026 in Review

Geode Capital Management held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 93,555 shares worth $96.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Geode Capital Management first reported a position in NMTC in Q1 2022 and has held it in 19 quarters since. The position peaked at $478K in Q1 2026. 18 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • Geode Capital Management held 93,555 shares of NeuroOne Medical Technologies worth $96.4K as of Q3 2026.
  • Geode Capital Management left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4069 holding.
  • Geode Capital Management first reported a position in NeuroOne Medical Technologies in Q1 2022 and has held it in 19 quarters since.
  • Geode Capital Management's NeuroOne Medical Technologies position peaked at $478K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.